The University of Chicago Header Logo

Nora T. Jaskowiak

Concepts (223)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
23
2024
3013
1.360
Why?
Neoadjuvant Therapy
8
2024
377
0.650
Why?
Neoplasm Recurrence, Local
9
2024
1365
0.500
Why?
Mastectomy
4
2015
246
0.390
Why?
Receptor, ErbB-2
3
2023
246
0.390
Why?
Carcinoma, Ductal, Breast
3
2022
159
0.380
Why?
Hyperparathyroidism
3
2002
67
0.380
Why?
Mastectomy, Segmental
3
2021
101
0.340
Why?
Parathyroid Neoplasms
2
2002
57
0.330
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
2567
0.300
Why?
Adenoma
2
2002
247
0.290
Why?
Neoplasm Staging
8
2021
2018
0.280
Why?
Aromatase Inhibitors
1
2006
29
0.270
Why?
Carcinoma, Intraductal, Noninfiltrating
2
2022
116
0.260
Why?
Sentinel Lymph Node Biopsy
2
2017
72
0.250
Why?
Lymphadenopathy
1
2024
20
0.230
Why?
Middle Aged
24
2024
25995
0.230
Why?
Positron Emission Tomography Computed Tomography
1
2024
96
0.220
Why?
Female
33
2024
46238
0.220
Why?
Carcinoma, Lobular
2
2015
81
0.210
Why?
Mammaplasty
3
2013
110
0.210
Why?
Technetium Tc 99m Sestamibi
1
2002
15
0.210
Why?
Lymph Nodes
2
2017
548
0.210
Why?
Reoperation
5
2013
601
0.200
Why?
Parathyroidectomy
1
2002
77
0.200
Why?
Parathyroid Hormone
1
2002
217
0.190
Why?
Radiopharmaceuticals
1
2002
196
0.190
Why?
Adenocarcinoma
5
2003
1198
0.190
Why?
Combined Modality Therapy
10
2023
1720
0.180
Why?
Intestinal Neoplasms
1
2001
67
0.180
Why?
Postoperative Complications
4
2013
2283
0.180
Why?
Adult
20
2024
26631
0.170
Why?
Body Weight
1
2021
452
0.170
Why?
Chemotherapy, Adjuvant
3
2024
487
0.160
Why?
Aged
16
2024
19178
0.160
Why?
Programmed Cell Death 1 Receptor
1
2020
173
0.160
Why?
Humans
37
2024
89391
0.160
Why?
Prognosis
7
2024
3787
0.160
Why?
Age Factors
1
2023
1872
0.160
Why?
Gastrinoma
1
1996
2
0.140
Why?
Zollinger-Ellison Syndrome
1
1996
10
0.140
Why?
BRCA1 Protein
1
2018
204
0.140
Why?
Urinary Catheterization
1
2016
36
0.130
Why?
Magnetic Resonance Imaging
3
2024
3448
0.130
Why?
Radiotherapy
3
2013
334
0.120
Why?
Ultrasonography
1
2017
712
0.120
Why?
Aged, 80 and over
9
2021
6817
0.120
Why?
Biopsy
3
2018
1185
0.120
Why?
Survival Rate
4
2024
1903
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2020
969
0.120
Why?
Early Detection of Cancer
1
2018
417
0.120
Why?
Crohn Disease
1
2001
762
0.120
Why?
Phyllodes Tumor
1
2013
7
0.120
Why?
Follow-Up Studies
5
2024
3667
0.110
Why?
Mass Screening
1
2018
637
0.110
Why?
Esophageal Neoplasms
4
2003
332
0.100
Why?
Lymphokines
3
2002
76
0.100
Why?
Retrospective Studies
8
2022
9060
0.100
Why?
Neoplasm, Residual
2
2023
181
0.100
Why?
Health Knowledge, Attitudes, Practice
1
2016
538
0.100
Why?
Pancreatic Neoplasms
1
1996
674
0.090
Why?
Endothelial Growth Factors
2
2002
55
0.090
Why?
Proportional Hazards Models
3
2021
852
0.090
Why?
Clinical Competence
1
2016
785
0.090
Why?
Paclitaxel
2
2019
479
0.090
Why?
Breast
2
2023
292
0.090
Why?
Genetic Therapy
2
2003
370
0.090
Why?
Mammography
3
2021
474
0.090
Why?
Peptide Fragments
2
2003
463
0.080
Why?
Time Factors
5
2013
5340
0.080
Why?
Neoplasm Proteins
2
2002
540
0.070
Why?
Endothelium, Vascular
4
2002
433
0.070
Why?
Cohort Studies
2
2023
2873
0.070
Why?
Prospective Studies
3
2021
4293
0.070
Why?
Tumor Cells, Cultured
6
2005
1057
0.070
Why?
Neoplasm Invasiveness
2
2019
576
0.060
Why?
Tamoxifen
1
2006
168
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2002
1266
0.060
Why?
Glycine
1
2005
95
0.060
Why?
Cyclophosphamide
1
2005
302
0.060
Why?
Adjuvants, Immunologic
1
2005
169
0.060
Why?
Tumor Necrosis Factor-alpha
3
2003
699
0.060
Why?
Radiation, Ionizing
2
2000
121
0.060
Why?
Antineoplastic Agents, Phytogenic
1
2005
277
0.050
Why?
Radiotherapy, Adjuvant
2
2015
296
0.050
Why?
Mucin-1
1
2003
45
0.050
Why?
Mice, Nude
5
2003
815
0.050
Why?
Intraoperative Period
1
2002
90
0.050
Why?
Adolescent
4
2015
9268
0.050
Why?
Collagen
2
2000
293
0.050
Why?
Antineoplastic Agents
2
2005
2415
0.050
Why?
Young Adult
3
2022
6317
0.050
Why?
Body Weights and Measures
1
2021
27
0.050
Why?
Coumarins
1
2000
13
0.050
Why?
Immediate-Early Proteins
1
2002
165
0.050
Why?
Neoplasm Transplantation
4
2005
397
0.050
Why?
Monitoring, Physiologic
1
2002
263
0.050
Why?
Carcinoma, Squamous Cell
2
2005
1097
0.040
Why?
Male
6
2016
42434
0.040
Why?
Neoplasm Grading
1
2021
374
0.040
Why?
Radiation-Sensitizing Agents
1
1999
97
0.040
Why?
Heterocyclic Compounds, 3-Ring
1
2019
31
0.040
Why?
Receptors, Steroid
1
2019
42
0.040
Why?
Trastuzumab
1
2019
74
0.040
Why?
Doxorubicin
1
2019
301
0.040
Why?
Neoplasms, Experimental
1
1999
269
0.040
Why?
Stress, Physiological
1
1999
232
0.040
Why?
Body Mass Index
1
2021
773
0.040
Why?
Mice
8
2005
11766
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2019
340
0.040
Why?
Axilla
1
2017
104
0.040
Why?
Survival Analysis
1
2021
1534
0.040
Why?
Comorbidity
1
2021
950
0.040
Why?
Anorexia
1
1997
30
0.040
Why?
Neovascularization, Pathologic
1
1999
364
0.040
Why?
Transplantation, Heterologous
3
2003
370
0.040
Why?
ROC Curve
1
2019
780
0.040
Why?
Thyroidectomy
1
1997
171
0.030
Why?
Antibodies, Monoclonal
2
2002
1412
0.030
Why?
Decision Trees
1
1996
59
0.030
Why?
Urinary Catheters
1
2016
6
0.030
Why?
Registries
1
2021
786
0.030
Why?
Case-Control Studies
1
2021
1863
0.030
Why?
DNA-Binding Proteins
1
2002
1242
0.030
Why?
Cross-Sectional Studies
1
2021
1714
0.030
Why?
Healthcare Disparities
1
2020
420
0.030
Why?
Lymphatic Metastasis
1
2017
502
0.030
Why?
Interleukin-6
1
1997
261
0.030
Why?
Neoplasms
2
2000
3043
0.030
Why?
Feasibility Studies
1
2017
782
0.030
Why?
Intraoperative Complications
1
1996
184
0.030
Why?
Protein Biosynthesis
1
1997
389
0.030
Why?
Protein Kinase Inhibitors
1
2019
605
0.030
Why?
Adipose Tissue
1
1997
259
0.030
Why?
Preoperative Care
1
1996
395
0.030
Why?
Transcription Factors
1
2002
1654
0.030
Why?
Surgical Procedures, Operative
1
1996
206
0.030
Why?
Education, Medical
1
2016
243
0.030
Why?
Cytokines
1
1997
803
0.030
Why?
Mice, Inbred C57BL
4
2000
3220
0.030
Why?
Transcription, Genetic
1
1997
1157
0.030
Why?
Animals
8
2005
27387
0.020
Why?
Adenoviridae
2
2003
349
0.020
Why?
Inflammation
1
1997
971
0.020
Why?
Genetic Vectors
2
2003
446
0.020
Why?
Umbilical Veins
2
2000
46
0.020
Why?
Carcinoma, Lewis Lung
2
2000
24
0.020
Why?
Vascular Endothelial Growth Factors
2
2002
56
0.020
Why?
Phosphatidylcholines
1
1990
49
0.020
Why?
Cells, Cultured
3
2000
2884
0.020
Why?
False Negative Reactions
1
2010
63
0.020
Why?
Radiation Tolerance
2
2002
173
0.020
Why?
Chromatography, High Pressure Liquid
1
1990
315
0.020
Why?
Genetic Predisposition to Disease
1
2018
2343
0.020
Why?
Promoter Regions, Genetic
2
2003
956
0.020
Why?
Gadolinium DTPA
1
2010
264
0.020
Why?
Vascular Endothelial Growth Factor A
2
2002
424
0.020
Why?
Mutation
1
2018
4143
0.020
Why?
Recombinant Proteins
2
2000
1012
0.020
Why?
Dose-Response Relationship, Drug
2
2000
1942
0.020
Why?
Diagnosis, Differential
1
2010
1597
0.020
Why?
Escherichia coli
2
2000
605
0.020
Why?
Sensitivity and Specificity
1
2010
2014
0.020
Why?
Radiodermatitis
1
2005
10
0.020
Why?
Injections, Intraperitoneal
1
2005
101
0.020
Why?
Contrast Media
1
2010
1092
0.020
Why?
Mice, Inbred C3H
1
2005
371
0.020
Why?
Drug Synergism
1
2005
306
0.010
Why?
Apoptosis
2
2002
1717
0.010
Why?
Xenograft Model Antitumor Assays
1
2005
470
0.010
Why?
Risk Factors
1
2013
5497
0.010
Why?
Multivariate Analysis
1
2005
988
0.010
Why?
Wound Healing
1
2005
359
0.010
Why?
Luminescent Proteins
1
2003
144
0.010
Why?
Random Allocation
1
2003
327
0.010
Why?
Early Growth Response Protein 1
1
2002
56
0.010
Why?
RNA, Messenger
2
1999
2017
0.010
Why?
Green Fluorescent Proteins
1
2003
309
0.010
Why?
Cell Line, Transformed
1
2002
155
0.010
Why?
Models, Animal
1
2003
276
0.010
Why?
Virus Replication
1
2003
324
0.010
Why?
Isocoumarins
1
2000
7
0.010
Why?
Collagen Type XVIII
1
2000
4
0.010
Why?
Endostatins
1
2000
6
0.010
Why?
Mitogen-Activated Protein Kinases
1
2002
227
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
46
0.010
Why?
Dose-Response Relationship, Radiation
1
2000
188
0.010
Why?
Pichia
1
2000
29
0.010
Why?
Chicago
1
2005
1427
0.010
Why?
Laminin
1
2000
89
0.010
Why?
Drug Combinations
1
2000
203
0.010
Why?
Proteoglycans
1
2000
123
0.010
Why?
Microcirculation
1
2000
104
0.010
Why?
Cell Separation
1
2000
198
0.010
Why?
Tumor Stem Cell Assay
1
1999
37
0.010
Why?
Cloning, Molecular
1
2000
646
0.010
Why?
RNA, Neoplasm
1
1999
88
0.010
Why?
Cell Survival
1
2002
983
0.010
Why?
Culture Media, Conditioned
1
1999
103
0.010
Why?
Flow Cytometry
1
2000
691
0.010
Why?
Disease Progression
1
2002
1489
0.010
Why?
Ciliary Neurotrophic Factor
1
1997
1
0.010
Why?
Leukemia Inhibitory Factor
1
1997
4
0.010
Why?
Cell Movement
1
2000
784
0.010
Why?
Growth Inhibitors
1
1997
42
0.010
Why?
Glioblastoma
1
1999
265
0.010
Why?
Leptin
1
1997
102
0.010
Why?
Interleukin-4
1
1997
130
0.010
Why?
Interleukins
1
1997
129
0.010
Why?
Interleukin-2
1
1997
251
0.010
Why?
Interleukin-10
1
1997
151
0.010
Why?
Immunohistochemistry
1
2000
1800
0.010
Why?
Lipopolysaccharides
1
1997
293
0.010
Why?
Melanoma
1
1999
468
0.010
Why?
Recurrence
1
1997
1144
0.010
Why?
Kinetics
1
1997
1528
0.010
Why?
Nerve Tissue Proteins
1
1997
511
0.010
Why?
Proteins
1
1997
787
0.010
Why?
Chromatography, Thin Layer
1
1990
32
0.010
Why?
Signal Transduction
1
2002
3387
0.010
Why?
Treatment Outcome
1
2002
8247
0.010
Why?
Lung Neoplasms
1
1999
2364
0.000
Why?
Diabetes Mellitus
1
1990
742
0.000
Why?
Jaskowiak's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (223)
Explore
_
Co-Authors (32)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_